JPJennifer L. Pluznick

Jennifer L. Pluznick

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jennifer L. Pluznick has a total of 196 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Novel roles of GPCRs in the renal collecting duct

    by Mackenzie K. Kui, Jessica J. Zhang, Jennifer L. Pluznick

    GPCRs serve to coordinate renal collecting duct function, orchestrating fine-tuned regulation of water, electrolyte, and acid–base homeostasis. Classical GPCRs such as the vasopressin V2 receptor (V2R) have well-established roles: the V2R serves to regulate water reabsorption, and V2R dysregulation can underly diabetes insipidus. However, transcriptomic and phosphoproteomic advances have revealed a diverse repertoire of understudied GPCRs expressed in the collecting duct whose physiological roles remain largely undefined. Here, we review emerging insights into three such receptors—GPR39, ADGRF5, and ADGRG3—highlighting their distinct contributions to collecting duct function. We also discuss atypical GPCR-related signaling, including PKD1 and MAGED2, which expand the conceptual framework of GPCR biology in renal function. Collectively, these findings illustrate that GPCRs play diverse and underappreciated roles in collecting duct physiology and pathophysiology, and that continued mechanistic studies may uncover new therapeutic opportunities for kidney disease.


  • Open Access

    Novel Advances in Our Understanding of Sex-Dependent Control of Blood Pressure

    by Rachel Q. Muir, Jiaojiao Xu, Alexandra D. Medcalf, Jennifer L. Pluznick

    Sex differences in blood pressure are evident from puberty through menopause, with premenopausal females exhibiting lower blood pressure than males. This review discusses key factors contributing to sex differences in blood pressure, focusing on the normotensive state. Key contributions from a number of systems are discussed, including cardiovascular and renal function, oxidative stress, immune cell involvement, the microbiome, and the roles of the nervous system and renin-angiotensin-aldosterone system. Additionally, we highlight novel advances in the field, including findings related to the G protein–coupled estrogen receptor (GPER), Klotho, olfactory receptor 558 (OLFR558), and the four-core genotype (FCG) model. Insights from clinical data and their implications for hypertension management are also considered. In sum, this review aims to integrate current knowledge on sex differences in blood pressure regulation to inform future research and clinical care.


  • GPR39 activation inhibits AQP2 trafficking and alters cytoskeletal organization

    by Mackenzie K. Kui, Jessica J. Zhang, Ibrahim A. Ahmed, Shishir Kumar Patel, Tara Fallah Rastegar, Hamid Rabb, Jennifer L. Pluznick

    This study presents the first exploration of the cellular and molecular mechanisms underlying GPR39 activation in a physiologically relevant in vitro model of the renal collecting duct, mpkCCD cells. Our findings implicate GPR39 in the regulation of aquaporin-2 expression and trafficking, cytoskeletal organization, and cellular metabolism. In addition, RNA sequencing of GPR39-activated cells revealed transcriptomic changes related to immune signaling, stress response, and differentiation.


  • Open Access

    Chronic Psychologic Stress in Mice Induces Kidney Inflammation

    by Tara F. Rastegar, Shishir K. Patel, Radhika Kapoor, Ryo Matsuura, Jackson Freiman, Brianna C. Bullock, Paul Welling, Jennifer Pluznick, Chirag R. Parikh, Deidra C. Crews, et al.

    Key Points: Chronic stress elevates neutrophil gelatinase-associated lipocalin and cystatin C. Chronic stress increases T helper 17 and regulatory T-cell populations in the kidney. Chronic stress could increase susceptibility to kidney diseases. Background: Chronic stress (CS) due to prolonged exposure to negative life events increases the risk of psychiatric illnesses and significantly affects physiologic processes. CS has also been linked to sustained systemic inflammation, resulting in dysregulated immune responses and organ function. We hypothesized that CS would lead to kidney inflammation and tested this in mice. Methods: Male C57BL/6J mice were subjected to CS by pair-housing them with CD-1 retired breeder mice. Kidney immune cells were isolated and evaluated by spectral flow cytometry. Cytokines were measured using a multiplex assay in kidney tissue and serum. Serum creatinine, cystatin C, and neutrophil gelatinase-associated lipocalin levels were measured. Results: Mice subjected to CS exhibited greater weight gain than the control group and had reduced fur quality. CS led to a decrease in the percentage of kidney CD4 + T cells (54.26%±0.89% versus 59.88%±1.25%, P < 0.001) and an increase in T helper 17 (2.3%±0.3% versus 0.83%±0.15%, P < 0.001) and regulatory T cells (3.42%±0.45% versus 1.53%±0.21%, P < 0.001). There was an increase in the kidney macrophage percentage in CS mice (88.33%±1.16% versus 84.26%±0.73%, P < 0.01). TNF- α levels were higher in the kidney of stressed mice (8.53±1.18 versus 3.15±1.29 pg/ml, P < 0.01). CS led to elevated levels of serum cystatin C (515.9±16.88 versus 456.6±14.79 ng/ml, P < 0.05) serum neutrophil gelatinase-associated lipocalin (833.1±282.4 versus 90.58±5.57 ng/ml, P < 0.0001). Conclusions: CS in mice led to kidney inflammation and immunologic changes. These could predispose to acute and CKDs in which inflammation plays a pathogenic role.


  • Microbes and GFR in Health and CKD in Mice

    by Jiaojiao Xu, Eesha Verma, Jason Sanchez, Sepideh Gharaie, Sunyoung Jeong, Shishir Kumar Patel, Mahta Gooya, Xavier de la Rosa, Kunal Gupta, Markus M. Rinschen, et al.

    Key Points: Microbes regulate GFR in health and CKD in mice. Tubuloglomerular feedback initially contributes to the microbial modulation of GFR. Background: Microbes are implicated in a variety of host physiologic and pathophysiologic processes. In this study, we tested the hypothesis that microbes modulate GFR in health and CKD. Methods: To uncover the effect of gut microbiota on kidney function in health and in a CKD model, we examined GFR, plasma creatinine, and kidney histology in mice when gut microbes were manipulated. Results: In healthy mice, GFR was significantly increased when gut microbiota were either suppressed (oral antibiotics) or absent (germ-free). In mice challenged with adenine diet to induce CKD with impaired GFR, suppressing gut microbes with oral antibiotics also increased GFR. In females on an adenine diet, oral antibiotics increased GFR versus adenine alone on weeks 4 and 6. In males, oral antibiotics elevated GFR on week 2. Adenine diet significantly increased plasma creatinine and kidney fibrosis; this was suppressed by oral antibiotics in both sexes. To explore the mechanism, we tested the hypothesis that altered tubuloglomerular feedback contributes to elevated GFR using the sodium-glucose cotransporter 2 inhibitor empagliflozin; empagliflozin impairs Na + reabsorption in the proximal tubule, altering tubuloglomerular feedback. Empagliflozin impaired antibiotics-induced GFR increases on week 3 but not week 5, suggesting that altered tubuloglomerular feedback contributes to the initial increase in GFR. Conclusions: The microbiome plays a key role in “setting” baseline GFR by a mechanism that partially involves tubuloglomerular feedback, and suppressing gut microbes can elevate GFR even in CKD mice.


  • Top Cited Papers
    Open Access

    Microbiota and kidney disease: the road ahead

    by Patricia P. Bloom, Wendy S. Garrett, Kristina L. Penniston, Mari-Karoliina H. Winkler, Stanley L. Hazen, Jose Agudelo, Mangesh Suryavanshi, Ahmed Babiker, Dylan Dodd, Michael A. Fischbach, et al.

    More than 850 million individuals worldwide, accounting for 10–15% of the adult population, are estimated to have chronic kidney disease. Each of these individuals is host to tens of trillions of microorganisms that are collectively referred to as microbiota — a dynamic ecosystem that both influences host health and is itself influenced by changes in the host. Available evidence supports the existence of functional connections between resident microorganisms and kidney health that are altered in the context of specific kidney diseases, including acute kidney injury, chronic kidney disease and renal stone disease. Moreover, promising data from preclinical studies suggest that targeting of gut microbial pathways may provide new therapeutic opportunities for the treatment of kidney disease. This Roadmap describes current understanding of the mechanisms by which microorganisms regulate host organ function, the effects of kidney disease on the gut microbiome, and how these insights may contribute to the development of microbe-targeted therapeutics. We highlight key knowledge gaps that remain to be addressed and strategies for addressing these, outlining both the promise and the potential pitfalls of leveraging our understanding of the gut microbiota to better understand and treat kidney disease.


  • Renal Ghrelin-Family GPR39 Receptor and Urinary Concentrating Ability

    by Lingzhi Liu, Lena L. Rosenbaek, Mackenzie Kui, Samuel L. Svendsen, Annemette Overgaard Brethvad, Alexander Jakobsen, Laura V. Sparsoe, Aimi Hamilton, Mads V. Sørensen, Mathias Skov, et al.

    Key Points: This study provides the first functional documentation of the ghrelin receptor family member GPR39 in the kidney. GPR39 activation directly reduced the urine concentrating capacity by reducing the AVP-induced water permeability of the collecting duct. In parallel, GPR39 activation increased the K + excretion through a specific reduction of phosphorylated Na + -Cl − cotransporter in the distal convoluted tubule. Background: Low-calorie intake is associated with substantial changes in volume distribution and volume status in the body, resulting in reduced circulatory volume and a reduction in BP. Activation of the orphan receptor GPR39 dampens food intake and causes weight loss in a glucagon like peptide-1–dependent fashion. We speculated that appetite-regulating signaling might also be responsible for the circulatory volume contraction observed in response to anorectic states. Methods: To assess the effect of GPR39 fluid homeostasis, we combined in vivo , ex vivo , and in vitro studies to assess the effect of a selective GPR39 agonist (Cpd1324). Results: Oral gavage of Cpd1324 dose-dependently increased the water intake of wild-type (WT) C57BL/6J mice only and was completely absent in global GPR39 knockout mice. GPR39 is expressed in the distal convoluted tubule and collecting duct of the kidney, and WT mice exclusively showed Cpd1324-induced increase in urine production, increased K + excretion, and reduced urine concentrating capacity both at baseline and after an 8-hour water restriction compared with vehicle controls. Correspondingly, Cpd1324 reduced AVP-induced cAMP production and directly counteracted the AVP-induced water permeability in perfused cortical collecting ducts. Moreover, specific GPR39 activation reduced the baseline and AVP-stimulated abundance of phosphorylated pS256-aquaporin 2 and pT58-Na + -Cl − cotransporter and diminished the AVP-stimulated pS269-aquaporin 2 abundance in renal tubular suspensions. These effects were seen exclusively in GPR39 WT mice and not in knockout mice. Conclusions: These data suggest that Cpd1324 directly targets renal GPR39 to induce increased diuresis and consequently stimulate drinking behavior. We conclude that the activation of GPR39 causes diuresis by opposing AVP-induced Na + and Cl − reabsorption in the distal convoluted tubule and water reabsorption in the collecting duct.


  • Roles of sensory receptors in non-sensory organs: the kidney and beyond

    by Jiaojiao Xu, Blythe D. Shepard, Jennifer L. Pluznick

    Olfactory receptors (ORs), taste receptors and opsins are well-known for their pivotal roles in mediating the senses of smell, taste and sight, respectively. However, in the past two decades, research has shown that these sensory receptors also regulate physiological processes in a variety of non-sensory tissues. Although ORs, taste receptors and opsins have all been shown to have physiological roles beyond their traditional locations, most work in the kidney has focused on ORs. To date, renal ORs have been shown to have roles in blood pressure regulation (OLFR78 and OLFR558) and glucose homeostasis (OLFR1393). However, sensory receptors remain drastically understudied outside of traditional sensory systems, in part because of inherent challenges in studying these receptors. Increased knowledge of the physiological and pathophysiological roles of sensory receptors has the potential to substantially improve understanding of the function of numerous organs and systems, including the kidney. In addition, most sensory receptors are G protein-coupled receptors, which are considered to be the most druggable class of proteins, and thus could potentially be exploited as future therapeutic targets.


  • G‐protein‐coupled receptor 41 in cardiomyocytes: Effect of butyrate on intracellular Ca 2+ and sarcomere shortening

    by Youxiu Yao, Xiaomei Yang, Brittni N. Moore, Tianyue Zhu, Laeben Lester, Roger A. Johns, Jennifer L. Pluznick, Wei Dong Gao

    G‐protein‐coupled receptor 41 (GPR41) is a Gα i ‐coupled receptor activated by short‐chain fatty acids (SCFAs). Here, we tested that GPR41 is also expressed in cardiomyocytes and exerts a direct negative inotropic effect when activated by SCFA butyrate. Primary cardiomyocytes were isolated from wild‐type (WT) and GPR41 knockout (GPR41 −/− ) adult mice and intracellular Ca 2+ concentration and cell shortening were measured using the IonOptix system. RNA localization (RNAScope), quantitative real‐time polymerase chain reaction (qRT‐PCR), immunofluorescence staining, and western blot were used to examine the expression of GPR41 in adult primary cardiomyocytes of WT and GPR41 −/− mice. The effect of butyrate on shortening and intracellular Ca 2+ transient via GPR41 was also tested in cardiomyocytes. We demonstrated for the first time the presence of GPR41s on cardiomyocytes. Butyrate dose‐dependently decreased cell shortening and the amplitude of intracellular Ca 2+ transients in cardiomyocytes from WT but not GPR41 −/− mice. In WT cardiomyocytes, butyrate decreased caffeine‐mediated amplitudes of intracellular Ca 2+ transients from the sarcoplasmic reticulum (SR). Moreover, the inhibitory effects of butyrate on cell shortening and intracellular Ca 2+ were pertussis toxin (PTX)‐sensitive. Finally, butyrate decreased the activity of sarcoendoplasmic reticulum Ca 2+ ‐ATPase (SERCA) and cellular 3′‐5′‐cyclic adenosine monophosphate (cAMP) content. In conclusion, GPR41 is expressed on cardiomyocytes. Butyrate, a known GPR41 agonist, reduces cardiomyocyte shortening and intracellular Ca 2+ transient via decreasing Ca 2+ content in the SR by inhibiting SERCA activity in a PTX‐dependent manner. These findings establish that GPR41 is directly activated by SCFAs to decrease contraction and intracellular Ca 2+ transient, highlighting the potential inhibitory role of GPR41 in cardiomyocytes.


  • Commensal microbiota regulate aldosterone

    by Brittni N. Moore, Alexandra D. Medcalf, Rachel Q. Muir, Chudan Xu, Francine Z. Marques, Jennifer L. Pluznick

    We explore the role of the gut microbiome in regulating aldosterone, a hormone closely linked to blood pressure and cardiovascular disease. Despite the recognized importance of the gut microbiome in host physiology, the relationship with circulating aldosterone remains largely unexplored. We demonstrate that suppression of gut microbiota leads to increased levels of plasma and urinary aldosterone. These findings underscore the potential of the gut microbiota to influence aldosterone regulation, suggesting new possibilities for treating hypertension.